Heart 1998;80:1-2 ( July )

Editorial

Arterial or venous conduits for redo coronary artery bypass grafting?

The first 150 words of the full text of this article appear below.

Redo coronary artery bypass grafting (CABG) forms an increasing part of the coronary revascularisation workload and currently accounts for 4% of all CABG procedures in the UK¹ and 10-20% in the USA.^2-4 In this issue Dougenis and Brown report their experience of redo CABG using either at least one internal mammary artery (IMA) conduit or only venous conduits.⁵ Their main conclusion, after a mean follow up of seven years in 103 patients, is that those who received at least one IMA graft had an improved long term outcome in terms of freedom from recurrent angina, freedom from cardiac events, and actuarial survival, compared to those receiving only vein grafts. As their study was not randomised, however, how confident can we be that important clinical differences in the groups did not contribute significantly to differences in outcome?

The need for redo CABG and clinical implications of different conduits

The need for redo . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

WEB TOP TEN
Heart 2002 87: 345. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Bushe, C., Paton, C. (2005). The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link?. J Psychopharmacol 19: 76-83 [Abstract]  
• Emberson, J R, Whincup, P H, Lawlor, D A, Montaner, D, Ebrahim, S (2005). Coronary heart disease prevention in clinical practice: are patients with diabetes special? Evidence from two studies of older men and women. Heart 91: 451-455 [Abstract] [Full Text]  
• Smith, S. C. Jr, Jackson, R., Pearson, T. A., Fuster, V., Yusuf, S., Faergeman, O., Wood, D. A., Alderman, M., Horgan, J., Home, P., Hunn, M., Grundy, S. M. (2004). Principles for National and Regional Guidelines on Cardiovascular Disease Prevention: A Scientific Statement From the World Heart and Stroke Forum. Circulation 109: 3112-3121 [Full Text]  
• Wilson, S, Johnston, A, Robson, J, Poulter, N, Collier, D, Feder, G, Caulfield, M J (2003). Comparison of methods to identify individuals at increased risk of coronary disease from the general population. BMJ 326: 1436- [Abstract] [Full Text]  
• Sutcliffe, S. J, Fox, K. F, Wood, D. A, Sutcliffe, A., Stock, K., Wright, M., Akhras, F., Langford, E. (2003). Incidence of coronary heart disease in a health authority in London: review of a community register. BMJ 326: 20-20 [Full Text]  
• Martin, S C, Butcher, A, Martin, N, Farmer, J, Dobson, P M, Bartlett, W A, Jones, A F (2002). Cardiovascular risk assessment in patients with retinal vein occlusion. Br J Ophthalmol 86: 774-776 [Abstract] [Full Text]  
• Foo, K., Timmis, A. D (2002). Review: Managing the diabetic patient with angina. British Journal of Diabetes & Vascular Disease 2: 169-175 [Abstract]  
• Harrop, J, Donnelly, R, Rowbottom, A, Holt, M, Scott, A R (2002). Improvements in total mortality and lipid levels after acute myocardial infarction in an English health district (1995-1999). Heart 87: 428-431 [Abstract] [Full Text]  
• McManus, R J, Mant, J, Meulendijks, C F M, Salter, R A, Pattison, H M, Roalfe, A K, Hobbs, F D R (2002). Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ 324: 459-464 [Abstract] [Full Text]  
• Nair, D.R., Wierzbicki, A.S., Mikhailidis, D.P. (2001). Time to look beyond just lowering the serum concentration of low density lipoprotein - high density lipoprotein levels are also important. The Journal of the Royal Society for the Promotion of Health 121: 98-101 [Abstract]  
• Bhatnagar, D, Morgan, J, Siddiq, S, Mackness, M I, Miller, J P, Durrington, P N (2000). Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia. BMJ 321: 1497-1497 [Abstract] [Full Text]  
• Monkman, D (2000). Treating dyslipidaemia in primary care. BMJ 321: 1299-1300 [Full Text]  
• Adler, A. I, Stratton, I. M, Neil, H A. W, Yudkin, J. S, Matthews, D. R, Cull, C. A, Wright, A. D, Turner, R. C, Holman, R. R (2000). Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321: 412-419 [Abstract] [Full Text]  
• Berger, A. (2000). Science commentary: Echocardiography. BMJ 321: 218-219 [Full Text]  
• Molokhia, M., Oakeshott, P. (2000). Ethnic minorities have specific needs with regard to cardiovascular risk. BMJ 321: 112-112 [Full Text]  
• Altman, R., Rouvier, J., Scazziota, A. (2000). State-of-the-Art Review : Secondary Prevention of Myocardial Infarction: Beneficial Effect of Combining Oral Anticoagulant Plus Aspirin: Therapy Based on Evidence. CLIN APPL THROMB HEMOST 6: 126-134  
• Baker, S., Priest, P., Jackson, R. (2000). Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ 320: 680-685 [Abstract] [Full Text]  
• Robson, J., Boomla, K., Hart, B., Feder, G. (2000). Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. BMJ 320: 702-704 [Full Text]  
• Delaney, B. C, Fitzmaurice, D. A, Riaz, A., Hobbs, F D R. (1999). Can computerised decision support systems deliver improved quality in primary care?. BMJ 319: 1281-1281 [Full Text]